Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

SHOCKING: Clinicaltrialsgov | Mind Blowing Facts

Patients Already in Biohaven Epilepsy Trials Keep Dosing as FDA Pauses New Enrollment Over a Rodent Finding

Medical Daily

Ohio Opens a Cancer Navigator Office After a West Chester Family Spent His Final Weeks Fighting Paperwork

Ohio created a Pediatric Complex Care Navigation Program after Jayden Zurlinden died at 20. It is open to families at any income level.

Medical Daily

Earthquake Survivors Recorded 60 Seconds of Their Own Laughter and Played It Back Three Times a Day

Twenty survivors of the 2023 earthquakes recorded their own laughter and replayed it daily. Well-being scores rose, but there was no control group.

Medical Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Most Patients with Chronic Illness Would Join a Clinical Trial, but Two-Thirds Say Doctors Never Mention Them

Most patients say they would join a clinical trial, but two-thirds say a doctor never raised it. Here is what actually blocks enrollment.

Medical Daily

Researchers Identify an Ancient Immune Protein That May Explain Why Some Tumors Resist Checkpoint Drugs

Complement C3 produced within tumors kept immunosuppressive cells out and improved checkpoint immunotherapy response in mice, researchers report.

Medical Daily

Light-Activated Compounds Designed to Stand In for Lost Photoreceptors Restore Visual Behavior in Blind Animals

Barcelona-led researchers developed prosthe6, light-switchable molecules that substituted for lost photoreceptors and restored visual responses in mice.

Medical Daily

An Aging Protein Called EPS8 Drives Toxic Protein Clumping in ALS and Huntington's Models, Cologne Team Reports

Cologne researchers found the aging protein EPS8 drives toxic protein clumping in worm and human cell models of ALS and Huntington's disease.

Medical Daily

Read news from The Economist, FT, and more,
with one subscription

VA Launches a Randomized Trial Testing Whether Semaglutide Can Reduce Drinking in Veterans

The VA opened enrollment in CRAVE, a placebo-controlled trial of semaglutide for alcohol use disorder in more than 600 veterans at 18 medical centers.

Medical Daily

Fifteen volunteers spent 40 days inside a French cave without clocks, sunlight or phones and emerged believing only 30 days had passed

On March 14, 2021, fifteen volunteers, seven women and eight men aged between 27 and 50, entered the Lombrives cave in the French Pyrenees to begin a 40-day experiment with no clocks, no phones, no natural light and no contact with the outside world. Known as Deep Time, the project…

The Times of India

One Dose of Psilocybin Produces Measurable Brain Changes Lasting Up to 30 Days, New Human Study Finds

A Nature Communications study found one dose of psilocybin changed brain structure and activity for up to 30 days in 28 healthy adults. Here is what the findings mean for mental health research.

Medical Daily

Scientists Cracked the Bacterial Code Behind Powerful Anti-Cancer Drugs, and It Could Help Build Better Ones

Researchers decoded how bacteria naturally produce multiple anti-cancer drug variants, a Nature Communications finding that could accelerate development of improved cancer therapies.

Medical Daily

GLP-1 Drugs Are Now Being Tested Alongside Chemotherapy in Cancer Patients

A University of Arizona trial is testing GLP-1 drugs with chemotherapy in metastatic pancreatic, colorectal, and liver cancer patients. Here's what the study asks.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Imperial College London

Nature Communications

105 stories

University of Arizona

80 stories

the University of Arizona

75 stories

the University of Warwick

41 stories

University of Warwick

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.